跳至主要内容
临床试验/NCT05755425
NCT05755425招募中不适用

CPAP Versus High Flow Nasal Cannula Oxygen for the Treatment of Patients With Community Acquired Pneumonia Induced Acute Hypoxemic Respiratory Failure in the Ward

Evangelismos Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
2
主要终点
days free from ventilatory support

研究概览

简要总结

the study compares two non-invasive respiratory support modalities ie CPAP and High Flow nasal cannula oxygen for the treatment of severe hypoxemic respiratory failure attributed to Community acquired Pneumonia.

详细描述

CPAP and High Flow nasal cannula oxygen are two established modalities for non-invasive respiratory support . In COVID pandemic era both CPAP and HFNO were widely used in the ward for the treatment of COVID-19 induced acute hypoxemic respiratory failure in order to prevent progression to intubation. Head to head comparison between the two modalities mentioned for the treatment of severe hypoxemic respiratory failure is not available neither in COVID pneumonia or Community acquired pneumonia (CAP).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with age >18 year old.
  • Been hospitalized with community acquired pneumonia
  • hospitalized in common ward (not ICU)
  • Patients should have pneumonia- pulmonary infiltrates in chest-xray and hypoxemic respiratory failure.
  • Patients should be unable to keep: SpO2>93% with FiO2 50%, or SpO2 95% with FiO2 50% and have evidence of respiratory distress defined as Respiratory rate -RR>35/min

排除标准

  • Need for immediate or imminent intubation
  • not fit for escalation of treatment: defined as intubation, mechanical ventilation and ICU support.
  • Pregnant women
  • Contraindication to CPAP or HFNO

结局指标

主要结局

days free from ventilatory support

时间窗: 28 days

days without support with either mechanical ventilation, HFNO, CPAP

次要结局

  • treatment failure defined(28 days)
  • days under non-invasive respiratory support(28 days)
  • hospital length of stay(28 days)
  • intubation rate(28 days)
  • hospital mortality(28 days)
  • Partial pressure of oxygen PaO2 change at 2h, 12h and 24h(28 days)

研究者

发起方
Evangelismos Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

IOANNA SIGALA

Pulmonologist-Intensivist

Evangelismos Hospital

研究点 (2)

Loading locations...

相似试验